Pages that link to "Q79362973"
Jump to navigation
Jump to search
The following pages link to Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na( ),K( ),2Cl(-) Co-transporter-dependent cystic dilation (Q79362973):
Displaying 50 items.
- Autosomal dominant polycystic kidney disease: the last 3 years (Q24656249) (← links)
- The Role of Calcium and Cyclic AMP in PKD (Q26824644) (← links)
- Experimental therapies and ongoing clinical trials to slow down progression of ADPKD (Q27001230) (← links)
- Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease (Q27011660) (← links)
- Ex vivo modeling of chemical synergy in prenatal kidney cystogenesis (Q28487937) (← links)
- A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease (Q28588616) (← links)
- Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases (Q28591325) (← links)
- Phosphodiesterase 1A modulates cystogenesis in zebrafish (Q30588457) (← links)
- Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again (Q33660700) (← links)
- Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse (Q33783994) (← links)
- Treatment strategies and clinical trial design in ADPKD (Q34024396) (← links)
- Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease (Q34056378) (← links)
- Parasympathetic innervation regulates tubulogenesis in the developing salivary gland. (Q34138618) (← links)
- The cell biology of polycystic kidney disease (Q34149966) (← links)
- Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease (Q34162111) (← links)
- Downregulating hedgehog signaling reduces renal cystogenic potential of mouse models (Q34260011) (← links)
- Kidney: polycystic kidney disease. (Q34436755) (← links)
- Food Restriction Ameliorates the Development of Polycystic Kidney Disease (Q34500619) (← links)
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis (Q34573001) (← links)
- Cyclic AMP-mediated cyst expansion (Q34850793) (← links)
- Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling (Q35410778) (← links)
- Tolvaptan inhibits ERK-dependent cell proliferation, Cl−secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin (Q35543229) (← links)
- Chloride secretion by renal collecting ducts (Q35963369) (← links)
- Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models. (Q35993937) (← links)
- The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees (Q36003176) (← links)
- c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease (Q36109160) (← links)
- Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways (Q36312666) (← links)
- Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells (Q36355236) (← links)
- Loss of the ciliary kinase Nek8 causes left-right asymmetry defects (Q36509302) (← links)
- Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity. (Q36574749) (← links)
- Vasopressin antagonists in polycystic kidney disease (Q36697096) (← links)
- Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease (Q36736765) (← links)
- Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease (Q36746073) (← links)
- Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis (Q36960239) (← links)
- Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor (Q36977390) (← links)
- Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies (Q36988173) (← links)
- Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption (Q37145917) (← links)
- CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis (Q37288563) (← links)
- Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion (Q37604709) (← links)
- Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis (Q37658195) (← links)
- Polycystic kidney disease, cilia, and planar polarity. (Q37723498) (← links)
- Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells (Q37801469) (← links)
- Polycystic kidney disease: Pathogenesis and potential therapies (Q37819164) (← links)
- Drug discovery for polycystic kidney disease (Q37885161) (← links)
- Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? (Q38113091) (← links)
- Strategies targeting cAMP signaling in the treatment of polycystic kidney disease (Q38171193) (← links)
- Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease (Q38763176) (← links)
- Glucose promotes secretion-dependent renal cyst growth (Q38838454) (← links)
- New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development (Q39030255) (← links)
- Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model (Q39794329) (← links)